Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 4 | 5000.00 | 2571.29 | 7735.00 | 7335.75 | 1.0544 | 1.0713 | |
| BT-20 | 0 | uM | 4 | 5000.00 | 2571.29 | 7303.00 | 7335.75 | 0.9955 | 0.9941 | |
| BT-20 | 0 | uM | 4 | 5000.00 | 2571.29 | 6547.00 | 7335.75 | 0.8925 | 0.8551 | |
| BT-20 | 0 | uM | 4 | 5000.00 | 2571.29 | 6929.00 | 7335.75 | 0.9446 | 0.9260 | |
| BT-20 | Etoposide | 0.01 | uM | 4 | 5000.00 | 2571.29 | 7245.00 | 7335.75 | 0.9876 | 0.9836 |
| BT-20 | Etoposide | 0.31623 | uM | 4 | 5000.00 | 2571.29 | 6182.00 | 7335.75 | 0.8427 | 0.7861 |
| BT-20 | PLX-4720 | 0.1 | uM | 4 | 5000.00 | 2571.29 | 7383.00 | 7335.75 | 1.0064 | 1.0085 |
| BT-20 | Nilotinib | 0.01 | uM | 4 | 5000.00 | 2571.29 | 7575.00 | 7335.75 | 1.0326 | 1.0429 |
| BT-20 | Nilotinib | 0.1 | uM | 4 | 5000.00 | 2571.29 | 7511.00 | 7335.75 | 1.0239 | 1.0315 |
| BT-20 | Etoposide | 19.9526 | uM | 4 | 5000.00 | 2571.29 | 1960.00 | 7335.75 | 0.2672 | -0.1643 |
| BT-20 | PLX-4720 | 0.01 | uM | 4 | 5000.00 | 2571.29 | 7627.00 | 7335.75 | 1.0397 | 1.0522 |
| BT-20 | PLX-4720 | 3.1623 | uM | 4 | 5000.00 | 2571.29 | 7246.00 | 7335.75 | 0.9878 | 0.9838 |
| BT-20 | Nilotinib | 10 | uM | 4 | 5000.00 | 2571.29 | 1986.00 | 7335.75 | 0.2707 | -0.1570 |
| BT-20 | NVP-TAE684 | 0.0016596 | uM | 4 | 5000.00 | 2571.29 | 7744.00 | 7335.75 | 1.0557 | 1.0729 |
| BT-20 | Nilotinib | 1 | uM | 4 | 5000.00 | 2571.29 | 7697.00 | 7335.75 | 1.0492 | 1.0646 |
| BT-20 | NVP-TAE684 | 0.1 | uM | 4 | 5000.00 | 2571.29 | 7547.00 | 7335.75 | 1.0288 | 1.0379 |
| BT-20 | PLX-4720 | 10 | uM | 4 | 5000.00 | 2571.29 | 6358.00 | 7335.75 | 0.8667 | 0.8195 |
| BT-20 | Nilotinib | 19.9526 | uM | 4 | 5000.00 | 2571.29 | 2232.00 | 7335.75 | 0.3043 | -0.0893 |
| BT-20 | 0 | uM | 4 | 5000.00 | 2571.29 | 7980.00 | 7335.75 | 1.0878 | 1.1145 | |
| BT-20 | NVP-TAE684 | 3.1623 | uM | 4 | 5000.00 | 2571.29 | 5288.00 | 7335.75 | 0.7209 | 0.6108 |
| BT-20 | Etoposide | 0.0033113 | uM | 4 | 5000.00 | 2571.29 | 7869.00 | 7335.75 | 1.0727 | 1.0950 |
| BT-20 | PLX-4720 | 19.9526 | uM | 4 | 5000.00 | 2571.29 | 5722.00 | 7335.75 | 0.7800 | 0.6970 |
| BT-20 | Etoposide | 3.1623 | uM | 4 | 5000.00 | 2571.29 | 2973.00 | 7335.75 | 0.4053 | 0.1007 |
| BT-20 | NVP-TAE684 | 10 | uM | 4 | 5000.00 | 2571.29 | 2417.00 | 7335.75 | 0.3295 | -0.0401 |
| BT-20 | 0 | uM | 4 | 5000.00 | 2571.29 | 7820.00 | 7335.75 | 1.0660 | 1.0863 |